Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: PRINCETON BIOMEDITECH CORP
Awarding agency: Department of Defense / Department of the Air Force
Funding agency: Department of Defense / Department of the Air Force
Period of performance: 2021-09-20 to 2022-03-31
Current total value of award: $9885816
Description: COVID-19 - INDUSTRIAL BASE EXPANSION